NEWTOWN, PA — Helius Medical Technologies, Inc. announced that it has continued expanding its position in Solana (“SOL”) tokens as part of its digital asset treasury strategy, bringing its total holdings to more than 2.2 million SOL.
The company also reported holding over $15 million in cash, earmarked to support further Solana acquisitions. Based on a SOL price of $232.50 as of October 6, the combined value of Helius’s Solana and cash holdings now exceeds $525 million — surpassing the gross proceeds from its initial private placement offering, which closed on September 18.
These purchases reflect what the company described as a long-term commitment to the Solana ecosystem and a belief in the blockchain’s future role within decentralized finance and enterprise infrastructure.
“Following in the footsteps of Michael Saylor at MSTR and Tom Lee at BMNR, HSDT Solana Company is focused on maximizing shareholder value by efficiently accumulating Solana,” said Cosmo Jiang, General Partner at Pantera Capital and Board Observer at HSDT. “As evidence of that focus, HSDT’s Solana and cash holdings now exceed the initial capital raise amount in less than three weeks.”
Joseph Chee, Executive Chairman of HSDT and Chairman of Summer Capital, noted the company’s growing traction among institutional investors. “HSDT Solana Company’s investment narrative is resonating with institutional investors,” he said. “We are encouraged by the strong interest coming out of Asia after the major digital assets conferences last week, and we look forward to continuing to be a leading advocate for the Solana ecosystem to a whole new set of investors.”
The company’s latest moves position Helius as one of the most prominent public firms aligning its treasury strategy with Solana, signaling increased corporate confidence in digital assets as long-term stores of value and strategic investments.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.